Tag: Fund
21 Invest launches specialized healthcare fund. Maximum target of 150 million euros
(Finance) – 21 Investan investment group founded by Alessandro Benetton, has the 21 Invest Healthcare fund was launchedwith a first closing of approximately 70 million euros and a maximum target…
Sale of Doliprane to an American fund: are we heading towards a shortage of this drug? Answers from an expert
News Published on 10/14/2024 at 4:18 p.m. updated on 10/14/2024 at 4:18 p.m. Reading 3 min. The Sanofi laboratory has announced its intention to sell its subsidiary Opella, notably producing…
Development and cohesion fund: the Government assigned cohesion resources to Campania, Umbria and Lampedusa in CIPESS
(Finance) – The Interministerial Committee for Economic Planning and Sustainable Development (CIPESS), approved a new substantial package of proposals for the allocation of financial resources for territorial cohesion. The Prime…
Exor, Noam Ohana launches his own fund but continues to manage Ventures portfolio
(Finance) – Exora holding company listed on Euronext Amsterdam and controlled by the Agnelli family, announced that Noam Ohanawho led Exor’s early-stage investments, has decided to launch his own fund.…
Climate change adaptation fund: “We must also ask businesses to make efforts”
After episodes of drought and heatwave this summer then floods which caused significant damage in France, particularly in the South-East last week, the Prime Minister is presenting this Friday, October…
who is behind the CD&R fund, new owner of Opella? – The Express
After major negotiations between Sanofi and the State, the most consumed French drug will come under the control of an American fund. Monday October 21, the French pharmaceutical group Sanofi…
Green light from France for the sale of Doliprane to the American fund CD&R after an agreement
Concerning the Doliprane sale file, the French government announced, on Sunday October 20, the signing of a “ tripartite agreement » between the State, Sanofi and the American investment fund…
the French investment fund PAI improves its offer for Opella – L’Express
New twist in the sale of Doliprane: the French fund PAI, whose offer was not accepted by Sanofi last week, would have bid higher to buy the subsidiary of the…
Will we still find Doliprane in France after its sale to an American fund? At what price?
The Sanofi subsidiary Opella, which produces and markets Doliprane in France, should be sold to an American fund. What consequences could this transfer have on consumers? The French consume 8,000…
Sanofi confirms negotiations with an American fund – L’Express
The French pharmaceutical group Sanofi confirmed this Friday, October 11 that it was in exclusive negotiations with the American fund CD & R to sell it a majority stake in…